Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211): A 12-Week, Double-Blind, Randomized, Controlled Trial
Diabetes Care - United States
doi 10.2337/diacare.27.6.1335
Full Text
Open PDFAbstract
Available in full text
Date
May 25, 2004
Authors
Publisher
American Diabetes Association